Logo

PRAA

PRA Group, Inc.

PRAA

PRA Group, Inc. • NASDAQ
$16.20 ▼ -0.49% (-0.08)
Market Cap $632.14 M
52w High $23.97
52w Low $12.29
Dividend Yield 0%
P/E -1.85
Volume 159.26K
Outstanding Shares 39.02M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $314.147M ▲ $515.25M ▲ $-407.703M ▼ -129.781% ▼ $-10.43 ▼ $-352.255M ▼
Q2-2025 $290.734M ▲ $91.365M ▲ $42.374M ▲ 14.575% ▲ $1.08 ▲ $88.542M ▲
Q1-2025 $272.043M ▼ $87.561M ▼ $3.659M ▼ 1.345% ▼ $0.092 ▼ $42.056M ▼
Q4-2024 $295.944M ▲ $88.719M ▲ $18.456M ▼ 6.236% ▼ $0.47 ▼ $59.281M ▲
Q3-2024 $283.584M $83.494M $27.154M 9.575% $0.69 $56.087M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $107.454M ▼ $4.999B ▼ $4.015B ▼ $928.493M ▼
Q2-2025 $196.366M ▲ $5.435B ▲ $4.038B ▲ $1.337B ▲
Q1-2025 $189.322M ▲ $5.148B ▲ $3.868B ▲ $1.219B ▲
Q4-2024 $161.7M ▼ $4.931B ▼ $3.738B ▲ $1.135B ▼
Q3-2024 $191.74M $4.936B $3.654B $1.219B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q2-2025 $45.713M ▲ $-12.91M ▲ $-9.023M ▲ $20.27M ▼ $5.006M ▼ $-14.188M ▲
Q1-2025 $9.064M ▼ $-52.58M ▼ $-24.385M ▲ $85.63M ▼ $22.881M ▲ $-53.48M ▼
Q4-2024 $22.784M ▼ $42.93M ▲ $-198.637M ▼ $143.764M ▲ $-35.001M ▼ $41.766M ▲
Q3-2024 $28.922M ▲ $-35.036M ▼ $-87.638M ▲ $143.247M ▼ $22.515M ▲ $-36.085M ▼
Q2-2024 $25.114M $-29.489M $-111.406M $151.004M $10.33M $-30.826M

Five-Year Company Overview

Income Statement

Income Statement PRA Group’s revenue has grown again after a softer period, showing that purchased portfolios are generating more collections than in the prior year. Profitability has recovered from a recent loss, but earnings are still meaningfully below the strong levels seen a few years ago. Margins remain solid for this type of business yet are not at prior peaks, suggesting the company is operating well but not in an exceptionally favorable environment. Overall, the income statement points to a business that has stabilized and is improving, but still working its way back from a downturn.

Balance Sheet

Balance Sheet The balance sheet shows a company funded largely by debt, with borrowings rising over time while shareholders’ equity has edged down slightly. Total assets have grown modestly, reflecting continued investment in loan portfolios, but cash on hand is relatively small compared with the overall size of the balance sheet. This combination means the business is quite leveraged and depends heavily on its ability to refinance and manage debt prudently. Financial flexibility is present but not abundant, so balance-sheet discipline and credit market conditions are important ongoing watchpoints.

Cash Flow

Cash Flow Despite reporting profits recently, PRA Group’s cash flow from operations has been negative in the last two years, after being positive in earlier periods. Free cash flow has followed the same pattern, moving from healthy inflows a few years ago to outflows more recently. Capital spending is modest, so the main driver is how much cash is tied up in buying new portfolios versus what is collected. This gap between accounting earnings and cash generation is a key risk to monitor, as the model requires continuous cash recycling to remain comfortable.

Competitive Edge

Competitive Edge PRA Group operates with meaningful advantages: long experience in debt purchasing, extensive data on consumer behavior, and a large international footprint that smaller rivals struggle to match. Its scale, specialized analytics, and established compliance capabilities create real barriers to entry in an industry that is both complex and heavily regulated. At the same time, it competes in a crowded, price-sensitive market and faces ongoing regulatory and reputational scrutiny, which can affect costs and portfolio availability. Overall, the moat is credible but must be actively maintained through disciplined portfolio pricing, regulatory compliance, and cost control.

Innovation and R&D

Innovation and R&D The company’s innovation is centered on data, analytics, and digital tools rather than traditional research labs. PRA Group has been modernizing its systems, building a unified global technology platform, and deepening its use of proprietary models to value portfolios and tailor collection strategies. Recent moves, such as appointing a senior leader for data and analytics, indicate a long-term commitment to using advanced analytics and potentially AI to refine predictions and personalize customer engagement. Future upside could come from better pricing accuracy, more efficient collections, and selective expansion into new asset types, but these initiatives also need careful governance given regulatory sensitivities.

Summary

PRA Group today looks like a cyclical, data-driven financial services business that is recovering from a weaker period but has not fully returned to its earlier strength. Revenues and earnings have improved, yet cash generation has lagged, and leverage remains high, putting a premium on prudent funding and portfolio selection. The company’s edge largely comes from its scale, rich data history, and technology-enabled operations, supported by a stated customer-centric approach in a controversial industry. Looking ahead, execution on analytics and digital transformation, along with careful navigation of regulation and credit cycles, will likely determine whether recent improvements can translate into durable, cash-backed performance.

NEWS

November 17, 2025 · 8:05 AM UTC

PRA Group to Participate in Upcoming Investor Events

Read more

November 4, 2025 · 6:45 AM UTC

Merck Signs Agreement with Dr. Falk Pharma GmbH for Certain Development and Commercialization Rights to MK-8690 (PRA-052) an Investigational Anti-CD30 Ligand Monoclonal Antibody

Read more

November 3, 2025 · 4:05 PM UTC

PRA Group Reports Third Quarter 2025 Results

Read more

October 13, 2025 · 4:05 PM UTC

PRA Group to Announce Third Quarter 2025 Results on November 3

Read more

September 24, 2025 · 5:32 PM UTC

PRA Group Announces Pricing of Offering of €300 Million of 6.250% Senior Notes due 2032

Read more